{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-024532","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.724475+00:00","generated_at":"2026-06-28T16:35:41.251217+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"LeMaitre Q3 sales $38.4M (+5% organic), EPS $0.30 (-19%), declares $0.11 dividend","bullets":["Net income $6.5M (-13%), op. income $9.1M (-9%), gross margin 64.8% (+250 bps).","Cash & investments $67.1M after $58.7M stock offering; Artegraft debt paid off.","Q4 guidance: sales $39–41M (midpoint +7%), EPS $0.29–0.34 (-8% midpoint).","Quarterly dividend $0.11/share, payable Dec 2 to holders of record Nov 19.","Americas and EMEA grew 5% each, APAC up 16%; Delta variant deferred elective surgeries."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-024532","json":"https://secwatch.observer/filing/0001437749-21-024532.json","markdown":"https://secwatch.observer/filing/0001437749-21-024532.md","text":"https://secwatch.observer/filing/0001437749-21-024532.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774921024532/0001437749-21-024532-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774921024532/lmat20211028_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:35:41.251217+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}